In a phase I clinical trial, Lu et al. synthesized DOTAP cholesterol condensed to the tumor suppressor gene (TUSC2) expression plasmid (DOTAP:chol-TUSC2) since the TUSC2 gene is often inactivated in lung cancer. This evidence concerns the gene TUSC2 and lung cancer.